Cargando…

Identification of an IGF2BP2-Targeted Peptide for Near-Infrared Imaging of Esophageal Squamous Cell Carcinoma

Esophageal squamous cell carcinoma (ESCC) is one of the most lethal malignancies globally. Peptide-based tumor-targeted imaging is critical for ESCC imaging. In this study, we aim to identify a peptide-targeting IGF2BP2 that specifically binds to human ESCC for near-infrared imaging of esophageal ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shu, Wenbin, Xiao, Yitai, Wang, Lizhu, Liang, Mingzhu, Li, Zhihong, Wu, Xiangwen, Cao, Qingdong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654546/ https://www.ncbi.nlm.nih.gov/pubmed/36364436 http://dx.doi.org/10.3390/molecules27217609

Ejemplares similares

The relationship between IGF2BP2 and PPARG polymorphisms and susceptibility to esophageal squamous-cell carcinomas in the eastern Chinese Han population
por: Qiu, Hao, et al.
Publicado: (2017)

TMEM44-AS1 promotes esophageal squamous cell carcinoma progression by regulating the IGF2BP2-GPX4 axis in modulating ferroptosis
por: Yang, Ruotong, et al.
Publicado: (2023)

Targeting IGF2BP3 in Cancer
por: Liu, Xin, et al.
Publicado: (2023)

IGF2BP2 maybe a novel prognostic biomarker in oral squamous cell carcinoma
por: Wang, Xiangpu, et al.
Publicado: (2022)

Targeted imaging of esophageal adenocarcinoma with a near-infrared fluorescent peptide
por: Kang, Xiaoyu, et al.
Publicado: (2021)

Elevated expression of the IGF2 mRNA binding protein 2 (IGF2BP2/IMP2) is linked to short survival and metastasis in esophageal adenocarcinoma
por: Barghash, Ahmad, et al.
Publicado: (2016)

Exploration and validation of a combined immune and metabolism gene signature for prognosis prediction of colorectal cancer
por: Xiao, Yitai, et al.
Publicado: (2022)

Cytoplasmic IGF2BP2 Protein Expression in Human Patients with Oral Squamous Cell Carcinoma: Prognostic and Clinical Implications
por: Lin, Shu-Hui, et al.
Publicado: (2022)

RPS15 interacted with IGF2BP1 to promote esophageal squamous cell carcinoma development via recognizing m(6)A modification
por: Zhao, Yahui, et al.
Publicado: (2023)

Long noncoding RNA LIPH-4 promotes esophageal squamous cell carcinoma progression by regulating the miR-216b/IGF2BP2 axis
por: Xiao, Yuhang, et al.
Publicado: (2022)

Near infrared fluorescent peptide nanoparticles for enhancing esophageal cancer therapeutic efficacy
por: Fan, Zhen, et al.
Publicado: (2018)

IGF2BP3 as a potential tissue marker for the diagnosis of esophageal high-grade intraepithelial neoplasia
por: Zhang, Jingjing, et al.
Publicado: (2017)

Elevated expression of the RNA-binding protein IGF2BP1 enhances the mRNA stability of INHBA to promote the invasion and migration of esophageal squamous cancer cells
por: Wang, Juan-Juan, et al.
Publicado: (2023)

Long non‐coding RNA HOXC‐AS1 exerts its oncogenic effects in esophageal squamous cell carcinoma by interaction with IGF2BP2 to stabilize SIRT1 expression
por: Yang, Zhengwu, et al.
Publicado: (2022)

Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target
por: Shantha Kumara, HMC, et al.
Publicado: (2015)

Clinical Significance of an m6A Reader Gene, IGF2BP2, in Head and Neck Squamous Cell Carcinoma
por: Deng, Xiaoli, et al.
Publicado: (2020)

IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma
por: Hu, Yuan, et al.
Publicado: (2022)

Investigation of Igf-1, Igf-Bp3 and Igf-Bp5 levels in umbilical cord blood of infants with developmental dysplasia of the hip
por: DEMİREL, Esra, et al.
Publicado: (2023)

Long Non-Coding RNA CCAT2 Promotes the Development of Esophageal Squamous Cell Carcinoma by Inhibiting miR-200b to Upregulate the IGF2BP2/TK1 Axis
por: Wu, Xiaodan, et al.
Publicado: (2021)

Role of IGF2BP3 in trophoblast cell invasion and migration
por: Li, W, et al.
Publicado: (2014)

Identification of IGF2BP3 as an Adverse Prognostic Biomarker of Gliomas
por: Sun, Chao, et al.
Publicado: (2021)

IGF2BP2-induced circRUNX1 facilitates the growth and metastasis of esophageal squamous cell carcinoma through miR-449b-5p/FOXP3 axis
por: Wang, Chang, et al.
Publicado: (2022)

IGF2BP2 Polymorphisms Are Associated with Clinical Characteristics and Development of Oral Cancer
por: Chou, Chia-Hsuan, et al.
Publicado: (2020)

IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader
por: Hu, Xiaoge, et al.
Publicado: (2019)

A micro-peptide encoded by HOXB-AS3 promotes the proliferation and viability of oral squamous cell carcinoma cell lines by directly binding with IGF2BP2 to stabilize c-Myc
por: Leng, Fei, et al.
Publicado: (2021)

Evaluation of the Association of IGF2BP2 Variants With Type 2 Diabetes in French Caucasians
por: Duesing, Konsta, et al.
Publicado: (2008)

IGF2BP1, a Conserved Regulator of RNA Turnover in Cancer
por: Glaß, Markus, et al.
Publicado: (2021)

Investigation of IGF1, IGF2BP2, and IGFBP3 variants with lymph node status and esophagogastric junction adenocarcinoma risk
por: Tang, Weifeng, et al.
Publicado: (2018)

ALKBH5 promotes hypopharyngeal squamous cell carcinoma apoptosis by targeting TLR2 in a YTHDF1/IGF2BP2-mediated manner
por: Ye, Jing, et al.
Publicado: (2023)

Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma
por: Liu, Huidi, et al.
Publicado: (2020)

Upregulation of IGF2BP2 Promotes Oral Squamous Cell Carcinoma Progression That Is Related to Cell Proliferation, Metastasis and Tumor-Infiltrating Immune Cells
por: Zhou, Lijie, et al.
Publicado: (2022)

Identification of Two m6A Readers YTHDF1 and IGF2BP2 as Immune Biomarkers in Head and Neck Squamous Cell Carcinoma
por: Li, Shaojie, et al.
Publicado: (2022)

Interactive Effect of IGF2BP2 rs4402960 Variant, Smoking and Type 2 Diabetes
por: Nfor, Oswald Ndi, et al.
Publicado: (2020)

IGF2BP2 promotes colorectal cancer progression by upregulating the expression of TFRC and enhancing iron metabolism
por: Liu, Tian-yue, et al.
Publicado: (2023)

Identification of a novel peptide targeting TIGIT to evaluate immunomodulation of (125)I seed brachytherapy in HCC by near-infrared fluorescence
por: Zeng, Peng, et al.
Publicado: (2023)

IGF2BP1: A post-transcriptional “driver” of tumor cell migration
por: Stöhr, Nadine, et al.
Publicado: (2012)

Enhancement of LIN28B-induced hematopoietic reprogramming by IGF2BP3
por: Wang, Saifeng, et al.
Publicado: (2019)

IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis
por: Haase, Jacob, et al.
Publicado: (2020)

IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma?
por: Xi, Yufeng, et al.
Publicado: (2022)

Parkin regulates IGF2BP3 through ubiquitination in the tumourigenesis of cervical cancer
por: Sun, Xin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9ff79dkn5bteis95viisrkk503